Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preoperative Anxiety Levels and Postoperative Opioid Use in Patients Undergoing Arthroscopic Rotator Cuff Repair: A Prospective Cohort Study.

Orthopaedic journal of sports medicine·2026
Same author

The Limited Evidence Base for Multilevel Lumbar Interbody Fusion and Its Consequences for Clinical Conclusions: A Systematic Review.

Journal of clinical medicine·2026
Same author

Complication, revision, and readmission rates following reverse total shoulder arthroplasty in wheelchair-dependent patients.

Journal of shoulder and elbow arthroplasty·2026
Same author

Correction: Combination of bazedoxifene with chemotherapy and SMAC-mimetics for the treatment of colorectal cancer.

Cell death & disease·2025
Same author

Body Mass Index as a Risk Factor for Readmission Rates in Direct Anterior Approach Total Hip Arthroplasty.

Arthroplasty today·2025
Same author

No Clinically Significant Differences in Patient-Reported Outcomes and Range of Motion Between Early and Delayed Mobilization After Primary Distal Biceps Tendon Repair: A Systematic Review and Meta-analysis.

The American journal of sports medicine·2025

Related Experiment Video

Updated: Jun 23, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

Aromatase expression is increased in BRCA1 mutation carriers.

Ashwini L Chand1, , Evan R Simpson

  • 1Prince Henry's Institute of Medical Research, Clayton, Victoria 3168, Australia. ashwini.chand@princehenrys.org.

BMC Cancer
|May 19, 2009
PubMed
Summary

BRCA1 gene mutations increase aromatase levels, a key enzyme in estrogen production, in ovarian and breast tissues. This explains why cancers are more common in BRCA1 carriers, linking gene function to carcinogenesis.

More Related Videos

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

Related Experiment Videos

Last Updated: Jun 23, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

Area of Science:

  • Molecular biology
  • Genetics
  • Oncology

Background:

  • BRCA1 mutations are linked to increased ovarian and breast cancer risk.
  • The molecular mechanisms, particularly aromatase regulation, were not fully understood.
  • BRCA1 is known to negatively regulate aromatase expression in vitro.

Purpose of the Study:

  • To characterize aromatase gene (CYP19A1) expression in BRCA1 mutation carriers.
  • To investigate aromatase promoter activity in breast adipose and ovarian tissues.
  • To compare expression levels between BRCA1 carriers and unaffected controls.

Main Methods:

  • Quantification of aromatase transcripts (total and promoter-specific PII, PI.3, PI.4).
  • Analysis of tissue samples from prophylactic/therapeutic mastectomy and oophorectomy.
  • Comparison of gene expression in ovarian and breast tissues from BRCA1 carriers and controls.

Main Results:

  • Lack of functional BRCA1 protein correlated with higher aromatase levels in 85% of carriers.
  • Aberrant transcriptional regulation of aromatase was observed.
  • Increased promoter II/I.3 and I.4 transcripts in breast adipose; elevated promoter I.3 and II transcripts in the ovary.

Conclusions:

  • Understanding the BRCA1-aromatase link is crucial for explaining tissue-specific carcinogenesis in BRCA1 mutation carriers.
  • Aberrant aromatase regulation contributes to cancer risk in BRCA1 mutation carriers.
  • This research provides molecular insights into BRCA1-associated hereditary cancers.